equity research: buy case on ubs; hold cs
TRANSCRIPT
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
1/47
This document is a marketing communication and is not independent research prepared in accordance with legal requirements
designed to promote the independence of investment research and is not subject to a prohibition on dealing ahead of the
dissemination of investment research.
For Reg-AC certification, see the end of the text. Liberum Capital does and seeks to do business with companies covered in this
communication. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of
this report. Investors should consider this report as only a single factor in making their investment decision.
10 January 2013 European Equity Research
Road to Damascus: Long Paul vs. SaulSwiss Banks: BUY UBS; HOLD Credit Suisse
EUROPE | BANKS | UBSN VX | CSGN VX
We believe that UBSs decision to radically shrink the capital consumption of its value-destructive IB
division by a further 57%, and cut IB headcount by some 7,000 will more than double the Groups cap-
adjusted Return on Basel 3 Equity (RoB3E) from 11.2% in 2012 to 26.0% in 2015. With the capital released
we expect dividends of at least CHF1.10 by 2015 implying a sustainable yield of 7.4% with special
dividends taking the 2015-17e average yield to 11.9%. We believe that the effect of all this remains
markedly underappreciated by the market. BUY with a price target of CHF18. By contrast, CS remains
committed to its low-RoE IB division which by 2015 we estimate will still consume c60% of group capitalwhilst earning returns of just 5.2% - well below the cost of equity. An ongoing risk of cross-division
subsidisation will depress the rating. On this basis we believe that CS trades at around fair value. HOLD
but watch for any hint of shrinking and capital rationing at the IB, in which case there is the possibility of
an immediate 8-15% upside.
Dramatic cost reduction for UBS, less so at CS: By 2015e we expect UBS will have cut operating expensesby CHF3bn (13%) via a 15% reduction in headcount. CS will have reduced costs by a more mundane 4%,
CHF0.9bn, with a 4% decline in head count.
Rapidly improving capital positions for both UBS and CS: By YE14e UBS will have a Basel 3 core equitytier 1 of 13.6% (vs 3Q12: 9.3%), well in excess of its self imposed capital target. CS will have reached a less
impressive 11.0% (3Q12: 7.5%), but ahead of fully implemented regulatory requirements.
Stable/falling RWAs by 2014/15 imply both UBS and CS will be strongly cash generative: By YE 15e UBSwill achieve returns of 26% (capital & regulation adj.) on RWAs of CHF200bn. Declining RWAs and improving
capital ratios can allow for significant distributions eg. A potential dividend of CHF1.75 in 2015 (11.7% yield).
Similar logic implies a 7.7% yield for CS (although it is likely to deploy much of this cash in its IB in our view).
UBS has CHF24.6bn of unrecognised potential deferred tax assets (UPDTAs) due to historic losses. Weestimate an NPV for these of CHF 7.5bn (13% mkt cap, or CHF2.0/share) which bolsters our valuation case.
Valuation: We use a SoTPs valuation approach taking account of UBSs superior capital position and UPDTAsas well as the higher regulatory drag CS is likely to experience from coming regulatory changes. For a variety of
reasons we apply a higher multiple to UBS WM business. We suggest 18% relative upside for UBS vs. CS.
Cormac Leech
+44 (0)20 3100 [email protected]
Figure 1: Summary valuation and recommendations
Target price & ratings 1) Underlyi ng 2013E 2) U/L Reg&Cap adjust ed 2013E4
Rec PriceTarget
Price % Upside EPS PEx TCE1 p/TCE RoTCEDiv
Yld6Cap
surplus2Cap surp3
%mkt cap EPS PEx5CoreTCE p/TCE5 RoTCE
UBS CHF Buy 14.3 18.0 20% 1.22 12.3 12.0 1.2 10.9% 1.3% 2.5bn 4% 1.34 10.0 10.1 1.2 13.2%
CS CHF Hold 24.4 25.0 2% 2.40 10.2 22.3 1.1 11.0% 3.1% 0.5bn 2% 2.28 10.4 22.2 1.2 10.3%
Avg 11% 11.2 1.2 10.9% 2.2% 3% 10.2 1.2 11.7%
1. TCE=Tangible Common Equity per share ; 2. Surplus = equity capital surplus under fully loaded Basel III vs. 10% target; 3. surplus as % of market cap ; 4. 2013E Reg&CapAdjnumbers are ex 1-offs, ex UBS legacy assets, and after buying back shares to eliminate capital surplus ; 5. ratios calculated after deducting 2012-13E announced dividends, UBS
UPDTAs & value of capital allocated against legacy assets to increase comparability. 6. 2013e div yield. Share price data COB 7th January 2013. Source: Liberum Capital, Bloomberg
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
2/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
2 www.liberumcapital.com
Contents
UBS 22
Credit Suisse 33
Appendix 44
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
3/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 3
Road to Damascus: Long Paul vs.SaulWe Swiss are farmers, not hunter-gatherers. The asset management business suits ourcharacter as well as our historical position. Your investment banking business, though, has
never made a penny for your shareholders...1, Swiss National Bank to UBS Chairman in
2010
Both UBS and CS are reducing costs to address a weaker revenue
environment. However UBS plans a considerably more aggressive 57%
shrinkage in IB RWAs, vs 3Q12 level, via radical restructuring. By contrast CS
still maintains committed to its IB division which will consume 63% of Group
Capital by YE15e while generating returns on Basel 3 equity of only 5.2% (post
Basel 3/ Dodd Frank/cost savings). As a result by 2015, UBS will have a capital
and regulation adjusted RoB3E of 26.0% vs. only 13.3% for CS a divergencenot yet fully discounted in our view. Over time we expect UBS share price
outperformance may encourage CS to follow suit boosting fair value by 8-16%
UBS and CS face a sluggish revenue environment. We estimate by 2015 revenues
will be c 13-15% below 2010 levels. However both UBS and CS have credible plans
to reduce costs (figure 15) to counter subdued revenue outlook. We estimate cost
income ratios for both banks of 72-74% by 2015e from 2012e levels of 78-81%.
Figure 2: Summary underlying P&L excluding 1-offs*
% Ch
CHF bn 2010 2011 2012e 2013e 2014e 2015e 2011 2012e 2013e 2014e 2015e 2015/2010
Revenues
UBS 31.1 27.9 27.9 27.5 27.4 27.0 -10% 0% -1% 0% -1% -13%
CS 30.4 24.4 25.7 25.6 25.5 25.9 -20% 5% 0% 0% 2% -15%
Costs
UBS -23.9 -22.0 -22.5 -21.2 -20.3 -19.5 -8% 2% -6% -4% -4% -18%
CS -23.3 -21.2 -20.0 -19.6 -19.2 -19.2 -9% -5% -2% -2% 0% -18%
Cost change
UBS 1.9 -0.5 1.3 0.9 0.8
CS 2.1 1.1 0.4 0.4 0.0
Revenue adj, cost change
UBS -0.5 -0.5 1.1 0.8 0.5
CS -2.4 2.1 0.3 0.4 0.3
Cost Income
UBS 77% 79% 81% 77% 74% 72% 2% 2% 2% -4% -3% -5%
CS 77% 87% 78% 77% 75% 74% 10% 10% -9% -1% -1% -3%
PBTUBS 7.1 5.8 5.2 6.3 7.0 7.4 -18% -10% 20% 13% 5% 4%
CS 7.2 3.1 5.5 5.7 6.1 6.5 -57% 80% 4% 6% 7% -10%
*Excluding UBS STAB option volatility, business realignment costs, exception litigation, 1-off rebound gains, gains on disposals and other 1-offsSource: Company Reports; Liberum Capital
UBS: 13% PBT CAGR 2013-15e: On a summary divisional basis UBS we expect
the asset and wealth management business to grow at an average 11-17% over
2013-15e resulting in average underlying PBT growth for UBS of 13% despite only
modest PBT growth in the IB due to exiting of certain FICC business. For full UBS
divisional P&Ls, excluding 1-off items, see figures 36-43.
1h t t p : / / t i ny u r l . com / a thw 8 tm , Martin Taylor (former Barclays CEO) FT op-ed 2Nov2012.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
4/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
4 www.liberumcapital.com
Figure 3: UBS summary underlying divisional P&L
CHF bn 2010 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012 2013 2014 2015 2016 2017
Wealth Mgmt 2.4 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%
Retail & Corporate 1.8 1.7 1.6 1.8 1.8 1.8 1.8 1.7 -6% -3% 12% 0% -1% 0% -3%
Global Asset Management 0.5 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%
Investment Bank 2.2 1.1 0.9 0.8 1.0 1.0 1.0 1.1 -49% -15% -15% 29% 0% 1% 1%Wealth Management USA 0.3 0.5 0.8 1.1 1.3 1.3 1.4 1.5 86% 75% 32% 14% 6% 6% 3%
Centre Core 0.0 -0.2 -0.9 -0.8 -0.7 -0.6 -0.5 -0.5 -12% -15% -17% -11% -11%
Total Underlying PBT ex legacy 7.1 5.8 5.2 6.3 7.0 7.4 7.8 8.1 -19% -10% 20% 13% 5% 5% 4%
Centre- Legacy 0.0 0.0 0.0 -3.5 -3.5 -1.0 0.0 0.0
U/L PBT including legacy 7.1 5.8 5.2 2.8 3.5 6.4 7.8 8.1 -19% -10% -47% 29% 81% 21% 4%
1-offs 0.3 -0.4 -7.5 0.0 0.0 0.0 0.0 0.0
Reported PBT 7.4 5.4 -2.3 2.8 3.5 6.4 7.8 8.1
Group MI s -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 -0.3
U/L Attributable 5.3 4.2 3.8 4.6 5.2 5.5 5.8 6.0 -19% -11% 22% 13% 5% 5% 4%
U/L EPS 1.4 1.1 1.0 1.2 1.4 1.5 1.5 1.6 -19% -11% 23% 13% 5% 5% 4%
Basel 3 RWAs 380 380 266 226 211 200 192 195
RoTCE at 10% CT1* 13.8% 11.2% 11.7% 18.8% 24.0% 26.9% 29.6% 31.2%
*not adjusted for financial regulation (e.g. Dodd Frank, ring-fencing etc)Source: Company Reports; Liberum Capital
CS: 5% PBT CAGR 2013-15e: Similarly for CS in the asset and wealth
management divisions we forecast average 2013-15 annual PBT growth of 9-26%
resulting in group PBT growth of 5% despite flat PBT in the IB (due to sluggish FICC
revenues). For full divisional P&L, ex 1-off items, see figures 51-57.
Figure 4: CS summary underlying divisional P&L
2010 2011 2012e 2013e 2014e 2015e 2011 2012e 2013e 2014e 2015e
Wealth Mgmt 2.5 1.9 2.2 2.5 2.7 2.9 -26% 19% 9% 9% 9%
Corporate & Institutional 0.9 0.9 0.9 0.9 0.9 0.9 -2% 3% 0% 0% 3%
Investment Bank 3.6 0.1 2.7 2.6 2.6 2.6 nm nm -3% 0% 2%
Asset Management 0.5 0.6 0.3 0.5 0.6 0.6 18% -43% 47% 23% 9%
Corporate Centre -0.3 -0.3 -0.6 -0.7 -0.7 -0.6 19% 92% 14% 0% -8%
U/L Total PBT 7.2 3.1 5.5 5.7 6.1 6.5 -57% 80% 4% 6% 7%Rev 1-offs 0.2 1.0 -1.8
Cost 1-offs -0.6 -1.3 -0.8 -0.5 -0.3 -0.3
1-offs -0.4 -0.3 -2.6 -0.5 -0.3 -0.3
Reported Total PBT 6.8 2.7 3.0 5.2 5.8 6.3
Reported total check 6.8 2.7 3.0 5.2 5.8 6.3
U/L PAT 5.6 2.3 4.5 4.4 4.7 5.0
U/L Attributable 4.9 2.0 3.9 3.8 4.1 4.3
Basel 3 RWAs 398.7 330.0 298.7 277.4 284.7 295.4
U/L PBT/Avg RWAs 1.8% 0.8% 1.8% 2.0% 2.2% 2.2%
Ro B3E @10% CT1* 12.2% 5.6% 12.5% 13.3% 14.4% 15.0%
*not adjusted for financial regulation
Source: Company Reports; Liberum Capital
Below consensus for UBS and CS EPS by 2% and 8% respectively
For UBS we are on average 2% above consensus EPS and 2% below on revenues.
For CS we are on average 8% below consensus EPS and 10% below on revenues.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
5/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 5
Figure 5: Liberum revenue and EPS forecasts vs. Bloomberg consensus
% Ch
CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2012e 2013e 2014e 2015e 2016e 2017e
UBS
LC e u/l revenue bn 27.9 27.9 27.5 27.4 27.0 27.8 28.5 0% -1% 0% -1% 3% 3%
LC e reported revenue 29.8 25.6 27.5 27.4 27.0 27.8 28.5Consensus 25.5 27.3 28.2 28.1 n/a n/a -14% 7% 3% 0%
LCe/ Consensus 0% 1% -3% -4%
LC e Adj EPS 0.99 1.22 1.38 1.46 1.53 1.59 -11% 23% 13% 5% 5% 4%
Consensus 1.03 1.08 1.34 1.61 2.10 n/a -7% 5% 24% 20% 31%
LCe/ Consensus -4% 13% 3% -9% -27%
CS
LC e u/l revenue bn 25.7 25.6 25.5 25.9 5% 0% 0% 2%
LC e reported revenue 24.0 25.6 25.5 25.9
Consensus 24.4 27.0 28.4 30.6 -4% 10% 5% 8%
LCe/ Consensus -2% -5% -10% -15%
LC e Adj EPS 2.29 2.40 2.54 2.73 86% 5% 6% 8%
Consensus 1.84 2.51 2.90 2.99 50% 36% 16% 3%LCe/ Consensus 24% -4% -13% -8%
Source: Company Reports; Liberum Capital
For UBS sharp rise in RoB3E due to reduced CapitalConsumptionCapital consumption change 2011-15: down 47% for UBS; down 13% for CS
For Credit Suisse, the reduction in RWAs from YE11-YE15e is likely to be much less
than for UBS. From YE11-15e, UBS will have reduced its RWAs by 47% to
CHF200bn vs. a 13% decline for CS to CHF295bn.
Figure 6: UBS and CS Basel 3 RWAs CHFbn 2010-2017e
150
200
250
300
350
400
450
2010 2011 2012e 2013e 2014e 2015e 2016e 2017e
UBS CS
Source:
UBS RWA shrinkage implies a reduction in required capital of CHF18bn by YE15e
vs. YE11 equivalent (32% of mkt cap) vs. a decline in RWAs of only 14% for Credit
Suisse (11% of mkt cap).
UBSs Capital consumption will
drop by 47% 2011-2015 vs. a drop
of only 13% for CS
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
6/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
6 www.liberumcapital.com
2012-15e: UBS RoB3E will more than double; limited improvement for CS
Despite both banks making significant improvements in attributable income, UBS will
deliver a stronger increase in Cap&Reg adjusted RoB3E 2012-15e, rising from
11.2% to 26.0% compared to CSs more subdued rise from 9.8% to 13.3% for CS.
This divergence explains much of expected TSR outperformance we expect forUBS.
Figure 7: Change in RWAs and impact on Return on Basel 3 equity at 10% gearing
2011 2012e 2013e 2014e 2015e
RWAs Basel 3
UBS 380 266 226 211 200
CS 339 299 277 285 295
Capital requirement at 10%
UBS 38 27 23 21 20
CS 34 30 28 28 30
Cumul. Chnge in Capital requir ed
UBS (11) (15) (17) (18)
CS (4) (6) (5) (4)
Cumulative capital release as % mkt cap
UBS -20% -27% -30% -32%
CS -10% -16% -14% -11%
Attributable Income
UBS 4.3 3.8 4.6 5.2 5.5
CS 1.5 3.6 3.8 4.1 4.4
Return on Basel 3 equit y at 10% gearing to RWAs
UBS 11.2% 11.7% 18.8% 24.0% 26.9%
CS 4.0% 11.4% 13.3% 14.4% 15.1%
Return on Basel 3 equity adjusted for regulation*
UBS 10.7% 11.2% 18.1% 23.2% 26.0%
CS 2.7% 9.8% 11.5% 12.6% 13.3%
*assume minus CHF0.5bn net of tax impact for CS and minus CHF0.2bn impact for UBS due to Dodd Frank and Ring-Fencing etcSource: Liberum Capital
Comparing Return on Basel 3 equity (RoB3E) is more meaningful than RoTCE
due to differences in composition of TCE for both banks:
As figure 8 illustrates due to items such as unrealised losses from cash flow hedges,
TCE per share is 73% higher than Basel 3 equity regulatory capital for UBS vs. only
42% for CS which misleadingly depresses UBSs relative RoTCE. Since Basel 3
equity capital determines capital adequacy, RoB3E is a more meaningful
For UBS the underlying RoB3E will
more than double from 2012-
2015e vs. a much more muted
32% rise for CS mainly due to
differences in divergence in capital
consumption but also due to more
rapid earnings growth due to
business mix changes
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
7/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 7
Figure 8: Bridge from TCE to Basel 3 equity capital 3Q12
B3 equity =
100% Per Share
% Basel 3
RWAs
CHF bn UBS CS UBS CS UBS CS UBS CS
Shareholders equity 52.4 35.7 14.0 22.4
Goodwill -6.6 (8.9) -1.8 -5.6Mandatory convert 0.0 3.6 0.0 2.3
Tangible Common Equity 45.8 30.4 173% 142% 12.2 19.115.2
% 9.9%
Unrealised losses from Cash flow hedges -3.2 -12% 0% -0.9 0.0 -1.1% 0.0%
Treasury shares -0.7 -3% 0% -0.2 0.0 -0.2% 0.0%
ex Fair Value Own Debt (FVoD) -0.1 (0.3) -1% -1% 0.0 -0.2 0.0% -0.1%
Pension plan adjustments 0.0 2.8 0% 13% 0.0 1.8 0.0% 0.9%
Qualifying non controlling interest 0.0 3.2 0% 15% 0.0 2.0 0.0% 1.1%
Other Capital deductions (3.7) (1.8) -14% -8% -1.0 -1.1 -1.2% -0.6%
Basel II core tier 1 38.0 34.4 144% 160% 10.1 21.6
12.6%
11.2%
Ex non controlling interests (3.2) 0% -15% 0.0 -2.0 0.0% -1.1%
Deferred tax -5.3 (7.2) -20% -34% -1.4 -4.5 -1.8% -2.3%
Pension -3.8 -14% 0% -1.0 0.0 -1.3% 0.0%
StabFund Option -1.0 -4% 0% -0.3 0.0 -0.3% 0.0%Net Other deductions 0.0 (1.0) 0% -5% 0.0 -0.6 0.0% -0.3%
Basel III equity tier 1 co def 28.0 22.9 106% 107% 7.5 14.4 9.3% 7.5%
Libor rigging litigations/fines (1.5) (1.5) -6% -7% -0.4 -0.9 -0.5% -0.5%
Basel III equit y tier 1 LCe def 26.5 21.4 100% 100% 7.1 13.5 8.8% 7.0%
#shares outstanding diluted 3.7 1.6
Basel 3 RWAs 301 307
Attributable 2012e 3.8 3.2
RoTCE 8.3%
10.7
%
Ratio of RoTCE for CS vs. UBS in 2012** 1.3x
RoB3CT1 14.3% 15.1%
Ratio of RoB3CT1 for CS vs. UBS in2012** 1.1x
*Fully loaded; CS returns are higher due to a lower capital ratio.Source: Company accounts; Liberum Capital
Figures 9 and 10 show our forecasted returns for UBS and CS on an i) underlying
basis ii) After assuming a buyback/ special dividend to eliminate excess capital iii)
After also adjusting for the earnings drag from more onerous regulation: By 2015 on
a FinReg and Cap adjusted basis we expect UBS and CS to achieve a RoB3E
of 26.0% and 13.3% respectively which is the most meaningful valuation
metric in our view
Figure 9: UBS underlying return on Basel 3 equity Figure 10: CS underlying return on Basel 3 equity
0%
5%
10%
15%
20%
25%
30%
2011 2012 2013 2014 2015
UBS underly ing UBS Cap Adj UBS FinReg Cap Adj
0%
5%
10%
15%
20%
25%
30%
2011 2012 2013 2014 2015
CS under ly ing CS Cap Adj CS F inReg Cap Adj
*FinReg: Financial Regulation such as Dodd Frank and Ring FencngSource: Liberum Capital
*FinReg: Financial Regulation such as Dodd Frank and Ring FencngSource: Liberum Capital
Analysis of composition of TCE
shows that a relatively large
proportion of UBSs tangible book
value is not eligible Basel 3 equity
capital which tends to misleadingly
understate relative returns on
equity vs. CS.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
8/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
8 www.liberumcapital.com
UBS could annually yield 11.9% 2015-17e; CS 8.6%UBS has scope to pay significant dividends: 9.5% by 2015e (7.4% sustainable)
Our base case forecasts UBS will pay a cash dividend equivalent to a 3.3% yieldin 2014, rising to a 9.5% in 2015-2017e. Despite this substantial yield, the Basel
3 core tier 1 continues to climb reaching 15.8% in 2017e.
Alternatively solving for a steady 13.6% Basel 3 equity ratio (the YE13e level)implies an average annual 11.9% yield over 2015-17.
The maximum sustainable underlying yield over the same period assuming 5%annual growth would be 7.9% (assuming 5% normalised RWA growth) implying a
4% annual special dividend from 2015-17e (i.e. 7.9%+4.0%=11.9%) as the
business transitions.
Put differently from YE14-YE17e, UBS will generate distributable cash ofCHF20.3bn after which a sustainable c8.4% dividend (from 2018e) looks feasible
equivalent to a payout ratio of c 80% growing broadly in line with invested assets,
with improving operating leverage roughly offsetting likely margin pressure.
Limiting the UBS capital ratio to
13.6% implies a 11.9% yield 2015-
17e of which 7.9% is sustainable
and 4% special
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
9/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 9
Figure 11: UBS dividend scenarios: conservative; targeting stable Basel 3 equity 2014-17e; long run sustainable dividend
CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e Avg 2015-17e
RWAs 380 266 226 211 200 192 195
Basel 3 equity 25 25 27 29 29 30 31
Basel 3 equity as % RWAs base case 6.7% 9.3% 11.8% 13.6% 14.2% 15.4% 15.8%
Statutory Attributable CHF 4.2 -3.1 2.1 2.8 5.2 6.4 6.6
Underlying Attributable 4.3 3.8 4.6 5.2 5.5 5.8 6.0
avg #shares bn 3.8 3.8 3.8 3.8 3.796 3.8 3.8
Adj EPS 1.11 0.99 1.22 1.38 1.46 1.53 1.59
i) Base case
Payout ratio statutory 9% -18% 36% 68% 102% 84% 81%
Payout ratio underlying 9% 15% 16% 36% 96% 91% 88%
Dividend CHF bn 0.4 0.6 0.7 1.9 5.3 5.3 5.3
Announced DPS 0.10 0.15 0.20 0.50 1.42 1.42 1.42
Current share price 15
Implied yield 0.7% 1.0% 1.3% 3.3% 9.5% 9.5% 9.5% 9.5%
ii) DIV for unch. Capital fro m 2014Basel 3 equity 25 25 27 29 27 26 25
Basel 3 equity % 6.7% 9.3% 11.8% 13.6% 13.6% 13.6% 13.0%
Payout ratio underlying 9.0% 15.1% 16.4% 36.2% 120% 127% 104%
Dividend CHF bn 0.4 0.6 0.7 4.8 6.6 7.4 6.3
DPS 0.10 0.15 0.20 0.50 1.75 1.95 1.66
Implied yield 0.7% 1.0% 1.3% 3.3% 11.7% 13.0% 11.1% 11.9%
iii) Sustainable Dividend
Underlying Attributable 4.3 3.8 4.6 5.2 5.5 5.8 6.0
RWAs 200 192 195
Assumed RWAs Growth 5% 5% 5%
RWA Growth CHF bn 10 10 10
Cap. Consumption @13% 1.3 1.3 1.3
Implied Payout ratio 76% 78% 79%
Implied DPS 1.1 1.2 1.3
Implied Yield 7.4% 8.0% 8.4% 7.9%
Source: Liberum Capital estimates
CS base case: cash dividend yield of 4.7% by 2015e
For CS the capacity to distribute cash is less impressive due to lower returns andless reduction in capital requirements. That said, our base case forecast of
2015e DPS of CHF 1.15 (underlying payout ratio of 42%) is still equivalent to a
4.7% yield.
Alternatively solving for a steady 11.0% Basel 3 equity ratio (the YE13e level)implies an average annual 8.6% yield over 2015-17.
For CS, we estimate the max sustainable yield to be 6.2% assuming 6% RWAgrowth (higher RWA growth than UBS given higher IB mix).
For UBS, in our base case despitepaying a dividend of CHF1.42 per
share from 2015e, yield of 9.5%,
the Basel 3 equity ratio continues
to climb to 15.8% by 2017e.
For UBS, solving for the dividend
required to keep the equity capital
ratio fixed at 13.6%, implies a
dividend of CHF 1.75 in 2015e and
an average yield 2015-17e of
11.9%
Assuming long run RWA growth of
5% (c NGDP) implies a payout
ratio of 79%, sustainable long term
dividend yield of 7.9%, growing at
perhaps 4-5% per annum
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
10/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
10 www.liberumcapital.com
Figure 12: CS dividend scenarios: conservative; targeting stable Basel 3 equity 2014-17e; long run sustainable dividend
CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e Avg 2015-17e
RWAs 339 299 277 285 295 304.3 313.4
Basel 3 equity 12 24 28 31 34 36.8 39.4
Basel 3 equity % 3.6% 8.2% 10.2% 11.0% 11.6% 12.1% 12.6%
Statutory Attributable CHF 1.6 3.1 3.5 3.9 4.2 4.4 4.6
Underlying Attributable 1.9 3.8 3.8 4.1 4.4 4.4 4.6
avg #shares bn 1.2 1.6 1.6 1.6 1.6 1.6 1.6
Adj EPS 1.58 2.37 2.40 2.54 2.73 2.87 3.01
i) Base case
Payout ratio statutory 55% 32% 39% 41% 44%
Payout ratio underlying 48% 26% 35% 39% 42% 43% 43%
Dividend CHF bn 0.9 1.0 1.4 1.6 1.8 2.0 2.1
Announced DPS 0.75 0.75 0.85 1.00 1.15 1.23 1.30
Current share price 24.38
Implied yield 3.1% 3.1% 3.5% 4.1% 4.7% 5.1% 5.3% 5.0%
ii) DIV for unch. Capital fro m 2014Basel 3 equity 12 24 28 31 32 33 34
Basel 3 equity % 3.6% 8.2% 10.2% 11.0% 11.0% 11.0% 11.0%
Payout ratio underlying 55% 32% 39% 79% 72% 78% 78%
Dividend CHF bn 0.9 1.0 1.4 3.1 3.0 3.4 3.6
DPS 0.75 0.75 0.85 1.00 1.88 2.14 2.26
Implied yield 3.1% 3.1% 3.5% 4.1% 7.7% 8.8% 9.3% 8.6%
iii) Sustainable Dividend
Underlying Attributable 1.6 3.1 3.5 3.9 4.2 4.4 4.6
RWAs 285 295 316.1 338.2
Assumed RWAs Growth 6% 6% 6% 6%
RWA Growth CHF bn 17 18 19 20
Cap. Consumpt ion @11% 1.9 1.9 2.1 2.2
Implied Payout ratio 51% 53% 52% 52%
Implied DPS 0.75 0.75 0.85 1.3 1.5 1.5 1.6
Implied Yield 3.1% 3.1% 3.5% 5.4% 6.0% 6.2% 6.4% 6.2%
Source: Company Reports; Liberum Capital
As a summary comparison, Figures 13 and 14 illustrate that UBS is likely to return
significantly more cash over the next 5 years under the various scenarios.
Figure 13: UBS dividend yield scenarios Figure 14: CS dividend yield scenarios
0.0%
5.0%
10.0%
15.0%
2 01 1 2 012 e 20 13 e 2 014 e 20 15 e 2 016 e 20 17 e
ba se c ase ma in ta in 1 3.6 % ca pita l s us ta in abl e
0.0%
5.0%
10.0%
15.0%
2011 201 2e 20 13e 2 014e 2015e 201 6e 20 17e
b ase cas e ma intain 11% capital s us tai nabl e
Source: Liberum Capital Source: Liberum Capital
Given UBSs significant cash generation, we see downside risk from potentiallyvalue destroying acquisitions. It remains to be seen whether management will
distribute the maximum appropriate level of capital to shareholders.
For CS, in our base case despite
paying a dividend of CHF1.15 per
share from 2015e, yield of 4.7%,
the Basel 3 equity ratio continuesto climb to 12.6% by 2017e
For CS, solving for the dividend to
keep the Basel 3 capital ratio at
11.0% in 2015e implies a dividend
of 1.88, yielding 7.7% and an
average 2015-17e yield of 8.6%
Assuming RWA growth of 6%
implies a payout ratio of 52% and
a sustainable yield of 6.2%
growing at perhaps 4%
UBS: Obvious future risk of
substantial cash generation
leading to complacency/ value-
dilutive M&A; manageable risk in
our view with the right
management incentives
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
11/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 11
Both UBS and CS undertaking significant cost saveinitiatives through 2015e likely to significantlyimprove PBT
UBS cost reduction plan, 2013-2015e Limited efficiency gains in 2012e: On an underlying basis UBS will increase
costs by CHF0.5bn in 2012 to CHF 22.5bn vs. 2011 adversely impacted by a
CHF0.6bn adverse FX move.
Mgmt target CHF4bn of cost saves by 2015e: From the 2012e cost run-rate ofCHF22.5bn, Management have committed to a further CHF4bn reduction by
2015 to cCHF18.5bn in 2015e, or CHF2.5bn net of CHF1.5bn of investment
spend.
We assume reduced investment spend due to weak revenues: Our own
forecasts assume underlying 2015e costs of 19.5bn (down CHF3.0bn from2012e), CHF0.5bn lower than management guidance in effect we are
forecasting that management will cut back on investment spend due to a weak
revenue environment. Our 2015e revenues are CHF1.1bn below consensus and
our 2015e EPS is conservatively 9% below Bloomberg consensus.
Our base case forecasts revenue-adjusted cost reduction of CHF2.3bn by2015e after changes in costs are adjusted for changes in revenues assuming a
marginal 75% cost income ratio vs. the 2012 run-rate.
Base case forecasted CHF3bn cost reduction looks achievable: equivalentto 13% of cost base and seems feasible given the planned 15% reduction in
headcount (10,000 staff) and also the IB business exits within credit and rates.
See figure 24 below for detailed analysis costs per employee by division for UBS.
CS cost reduction plan, 2013-2015e
Improved efficiency in 2012e: On an underlying basis CS reduced costs byCHF0.8bn in 2012e to CHF 20.3bn vs. 2011, reducing the clean cost income
ratio to 78% from the uncomfortably high 87% in 2011.
Management guide for CHF2bn reduction by 2015 (excluding variablecompensation) vs. 9M12 level. This would imply 2015e costs of c CHF18.3bn.
Our own forecasts assume underlying 2015e costs of 19.3bn down CHF0.9bn
from 2012e or CHF1.1bn higher than management guidance as we expectinvestment spend and other factors (such as e.g. regulatory spend, PAF3/ Bond
Plus etc) to significantly impact costs. As context, our 2015e revenues are
CHF4.7bn below consensus (admittedly small Bloomberg sample) and our EPS
is 8% below consensus. Reverse engineering this consensus implies consensus
2015e group costs of CHF23.2bn and a cost income ratio of 76% vs. our 74%
implying consensus cost reduction expectations (even revenue adjusted)
are lower than our own forecasts.
On a revenue adjusted basis where changes in costs are adjusted for changesin revenues assuming a marginal 75% cost income ratio, we forecast CS will
eliminate CHF1.0bn in costs by 2015e equivalent to 5% of total costs. This looksfeasible given
For UBS we assume CHF3bn of
cost reduction 2015e vs. 2012e
For CS we assume CHF0.9bn of
cost reduction by 2015e vs. 2012e.
Our 2015e CS cost income ratio of
74% is below an estimated
Bloomberg consensus 76%
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
12/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
12 www.liberumcapital.com
opportunities to rationalise FICC, Underwriting and advisory business in
some geographies
scope to consolidate back office systems.
high 2012e starting point cost income ratio of 78%
progress being made: the CHF1.8bn of cost saving progress achieved in
2012 also point to further efficiency gains over 2013-2015.
Figure 15 summaries our cost forecasts for UBS and CS
Figure 15: Cost reduction plans absolute and revenue adjusted.
2010 2011 2012 2013 2014 2015 2016 2017 Cumul. FY13-15 inclusive
Clean Revenues
UBS 31.1 27.9 27.9 27.5 27.4 27.0 27.8 28.5
CS 30.4 24.4 25.7 25.6 25.5 25.9Clean Costs
UBS 23.9 22.0 22.5 21.2 20.3 19.5 19.9 20.4
CS 23.3 21.2 20.0 19.6 19.2 19.2
Cost income ratio
UBS 77% 79% 81% 77% 74% 72% 72% 71%
CS 77% 87% 78% 77% 75% 74%
Clean PBT
UBS 7.1 5.8 5.2 6.3 7.0 7.4 7.8 8.1
CS 7.2 3.1 5.5 5.7 6.1 6.5
Change in Clean PBT
UBS -1.3 -0.6 1.0 0.8 0.4 0.4 0.3 2.2
CS -4.1 2.5 0.2 0.3 0.4 1.0
Change in Revenues
UBS -3.1 -0.1 -0.4 -0.1 -0.4 0.8 0.8 -0.9
CS -6.0 1.3 -0.1 -0.1 0.4 0.2Change in costs
UBS -1.9 0.5 -1.3 -0.9 -0.8 0.4 0.5 -3.0
CS -2.1 -1.1 -0.4 -0.4 0.0 -0.9
Assumed incremental Cost income ratio
UBS 75% 75% 75% 75% 75% 75% 75%
CS 75% 75% 75% 75% 75% 75% 75%
Cost change due to Revenue Change
UBS -2.3 -0.1 -0.3 -0.1 -0.3 0.6 0.6 -0.6
CS -4.5 1.0 -0.1 -0.1 0.3 0.1
Revenue adjusted cost reduction
UBS 0.5 0.5 -1.1 -0.8 -0.5 -0.2 -0.1 -2.3
CS 2.4 -2.1 -0.3 -0.4 -0.3 -1.0
Source: Company Reports; Liberum Capital
By YE15e UBS will have only 16% more staff than CS down from 30% currently
By 2015E UBS plans to have reduced head count by 15% to 54,000 down fromthe 3Q12 level of 63,700 mainly within the IB division where we estimate staff
reduction from 16,500 to 9,500 by YE15e.
By contrast Credit Suisse has publicly committed to staff cuts of only 2,000 fromthe 2Q11 levels, which were already largely complete by 3Q12 with a total staff
level of 48,400.
We estimate that Credit Suisse will cut a further 2,000 jobs by YE15e implyingtotal headcount of 46,400 (although CS has not given staffing level guidance-
Taking changes in revenue into
consideration we are forecasting
CHF2.3bn of cost reduction forUBS and CHF1.0bn for CS
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
13/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 13
apparently for legal reasons according to IR). We expect 1,500 of these cuts are
likely to be in the IB division (front and back-office)
By YE15e UBS will have only 16% more staff than CS down from 63% at YE08
and 30% at 3Q12e.
Figure 16: UBS headcount by division Figure 17: CS headcount by division
0
20
40
60
80
2008 2009 2010 2011 2012e 2013e 2014e 2015e
IB WM WMA R&C/ CIC GAM Centre
0
20
40
60
80
200 8 2009 2010 2011 2012e 2013e 201 4e 20 15e
IB WM R&C/CIC AM Centre
Source: Company Reports; Liberum Capital Source: Company Reports; Liberum Capital
Focusing on the change 2015 vs. 2012 shows a dramatic shrinkage in the IB head
count for UBS down 42% to 9,500 and down 7% for CS to 19,100.
Figure 18: UBS headcount changes Figure 19: CS headcount changes
010
20
30
40
50
60
70
Group Non IB IB
2012 2015
0
10
20
30
40
50
60
70
Group Non IB IB
2012 2015
Source: Company Reports; Liberum Capital Source: Company Reports; Liberum Capital
Our divisional cost forecasts imply relatively stable revenues and costs per
employee
As the tables below illustrate our forecasts imply a modest 6% uptick in revenues
per employee in 2015e vs. 2012e, for both UBS and CS to CHF0.57m and 0.55m
respectively with costs/employee essentially flat at CHF 0.36m and CHF0.41m
respectively. Staff costs/employee are up modestly (5% for UBS, 1% for CS)
respectively.
Figure 20: UBS Group revenue and costper employee , CHF m
Figure 21: CS Group revenue and costper employee, CHF m
0.00
0.10
0.20
0.30
0.40
0.50
0.60
Revenue Cost Staff cost
2012 2015
0.00
0.10
0.20
0.30
0.40
0.50
0.60
Revenue Cost Staff cost
2012 2015
Source: Company Reports; Liberum Capital Source: Company Reports; Liberum Capital
UBSs headcount is trending
towards that of CS: by 2015e UBS
will have just 16% more staff down
from 130% at 3Q12
UBS will IB staff by 42% by 2015
vs current levels.
We expect only 7% cuts for CS
Our assumed costs per employee
are relatively stable 2015 vs. 2012
with most of the savings from
headcount reduction
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
14/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
14 www.liberumcapital.com
IB division revenue and costs per FTE are relatively stable
Looking at the IB divisions in more detail, we expect cost per FTE will decline by 2%
for UBS to CHF0.47m and decline by 1% for CS to CHF0.51m.
IB Revenues per FTE are expected to rise by 6% for UBS to CHF0.57m as lessprofitable areas are exited and by 1% for CS to CHF0.65m.
Figure 22: UBS IB division revenue andcost per employee
Figure 23: CS IB division revenue andcost per employee
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
Revenue Cost Staff cost
2012 2015
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
Revenue Cost Staff cost
2012 2015
Source: Liberum Capital Source: Liberum Capital
In 2012 CS IB staff are 20% more
productive than UBSs in revenue
terms but also 7% more expensive
in total cost terms and 4% more
expensive in terms of average
compensation
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
15/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 15
For completeness we include the full cost and revenue per FTE table for UBS:
Figure 24: UBS Divisional costs and revenues per FTE
Head co unt
'000s 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
IB 16.9 17.3 16.5 14.4 12.5 9.5 -42%WM 15.7 15.9 16.3 15.3 15.1 15.6 -5%
WMA 16.3 16.2 16.2 16.3 16.0 15.2 -6%
R&C/ CIC 12.1 11.4 10.2 9.6 9.8 9.8 -4%
GAM 3.5 3.8 3.8 3.6 3.4 3.4 -11%
Centre 0.2 0.3 0.5 0.5 0.5 0.5 0%
Total 64.6 64.8 63.6 59.7 57.2 54.0 -15%
Clean Cost by Division
CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 5.0 4.9 4.8 4.7 4.8 4.9 1%
R&C/ CIC 2.1 2.1 2.1 1.9 1.9 1.9 -10%
GAM 1.5 1.3 1.4 1.3 1.3 1.3 -4%
IB 9.6 8.7 8.1 7.1 6.2 5.2 -36%
WMA 5.3 4.7 5.2 5.3 5.4 5.6 7%
Centre 0.4 0.3 0.8 0.9 0.7 0.6 -24%
Total 23.9 22.1 22.5 21.2 20.3 19.5 -13%
Staff cost by division
CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 3.2 3.3 2.9 2.9 2.9 3.0 6%
R&C/ CIC 1.6 1.7 1.4 1.3 1.3 1.3 -2%
GAM 1.1 1.0 0.9 0.9 0.9 0.9 -2%
IB 6.5 5.6 4.9 4.3 3.8 3.2 -36%
WMA 4.2 3.8 4.3 4.4 4.5 4.6 7%
Centre 0.1 0.1 0.3 0.3 0.3 0.3 -10%
Total 16.8 15.4 14.6 14.1 13.7 13.3 -9%
Implied loaded Cost per FTE
CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 0.32 0.31 0.30 0.30 0.31 0.32 6%
R&C/ CIC 0.17 0.18 0.20 0.19 0.20 0.20 0%
GAM 0.44 0.37 0.36 0.36 0.37 0.39 7%
IB 0.59 0.51 0.48 0.46 0.46 0.47 -2%
WMA 0.32 0.29 0.32 0.33 0.34 0.37 14%
Centre 1.97 0.96 1.48 1.58 1.35 1.13 -24%
Total 0.37 0.34 0.35 0.36 0.35 0.36 2%
Implied staff cost per FTE
CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 0.20 0.21 0.18 0.18 0.19 0.20 11%
R&C/ CIC 0.13 0.14 0.13 0.14 0.14 0.14 9%
GAM 0.32 0.26 0.24 0.24 0.25 0.26 9%
IB 0.40 0.33 0.29 0.28 0.28 0.29 -1%
WMA 0.25 0.24 0.26 0.27 0.28 0.29 11%
Centre 0.13 0.30 0.72 0.54 0.51 0.49 -32%
Total 0.26 0.24 0.23 0.23 0.23 0.24 5%
Revenue by division
CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 7.4 7.2 7.1 7.4 7.8 8.0 13%
R&C/ CIC 3.9 3.9 3.7 3.7 3.7 3.7 -1%
GAM 2.1 1.8 1.9 1.9 2.0 2.0 10%
IB 11.8 9.8 9.0 7.9 7.2 6.3 -31%
WMA 5.6 5.2 6.1 6.4 6.7 6.9 14%
Centre 0.4 0.0 0.0 0.0 0.0 0.0 nm
Total 31.1 27.9 27.9 27.5 27.4 27.0 -3%
Implied revenue per FTE
CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 0.47 0.46 0.44 0.47 0.51 0.52 18%
R&C/ CIC 0.33 0.33 0.35 0.38 0.38 0.38 9%
GAM 0.59 0.50 0.49 0.53 0.57 0.60 22%
IB 0.72 0.57 0.54 0.51 0.54 0.57 6%
WMA 0.33 0.32 0.38 0.40 0.42 0.45 19%
Centre nm nm nm nm nm nm nmTotal 0.48 0.43 0.43 0.45 0.47 0.49 12%
Source: Liberum Capital
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
16/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
16 www.liberumcapital.com
And similarly for CS:
Figure 25: CS Divisional costs and revenues per FTE
Head co unt
'000s 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
IB 20.7 20.9 20.6 19.6 19.6 19.1 -7%WM 20.5 20.2 19.3 19.3 19.1 19.2 0%
R&C/CIC 5.1 5.0 4.8 4.9 4.9 4.9 2%
AM 2.9 2.7 2.8 2.7 2.5 2.3 -18%
Centre 0.9 0.9 0.9 0.9 0.9 0.9 0%
Total 50.1 49.7 48.4 47.4 47.1 46.4 -4%
129% 130% 131% 126% 122% 116%
Clean Cost by Division
CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 7.2 7.0 6.2 6.2 6.2 6.2 -1%
R&C/CIC 1.0 0.9 1.0 1.0 1.0 1.0 4%
PB 8.2 7.9 7.2 7.2 7.2 7.2 0%
AM 1.8 1.6 1.6 1.5 1.4 1.4 -10%
IB 12.8 11.3 10.7 10.2 9.9 9.9 -8%
Centre 0.4 0.3 0.6 0.8 0.8 0.7 21%
Total 23.3 21.2 20.0 19.6 19.2 19.2 -4%
Staff cost by division
CHF bn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 4.2 4.0 3.6 3.6 3.6 3.6 -1%
R&C/CIC 0.6 0.6 0.6 0.6 0.6 0.6 6%
PB 4.7 4.6 4.2 4.2 4.2 4.2 0%
AM 1.1 0.9 1.0 0.9 0.9 0.9 -14%
IB 8.0 6.7 6.3 6.0 5.8 5.8 -9%
Centre 0.3 0.1 0.3 0.5 0.5 0.4 nm
Total 18.9 16.9 16.1 15.8 15.5 15.5 -4%
Implied loaded Cost per FTE
CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 0.36 0.34 0.32 0.32 0.32 0.32 2%
R&C/CIC 0.19 0.19 0.19 0.20 0.20 0.20 4%
AM 0.61 0.57 0.57 0.55 0.54 0.59 3%
IB 0.64 0.55 0.51 0.51 0.50 0.51 -1%
Centre 0.52 0.33 0.65 0.84 0.84 0.79 nm
Total 0.46 0.43 0.41 0.41 0.41 0.41 0%
Implied staff cost per FTE
CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 0.21 0.20 0.18 0.19 0.19 0.19 2%
R&C/CIC 0.11 0.11 0.12 0.12 0.12 0.12 6%
AM 0.36 0.33 0.36 0.34 0.33 0.36 -1%
IB 0.40 0.32 0.31 0.30 0.29 0.30 -2%
Centre 0.36 0.12 0.35 0.50 0.50 0.44 nm
Total 0.39 0.34 0.33 0.33 0.33 0.33 1%
Revenue
CHFbn 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 9.8 9.0 8.6 8.8 9.0 9.2 7%
R&C/CIC 1.8 1.8 1.9 1.9 1.9 2.0 4%
AM 2.3 2.1 1.9 2.0 2.0 2.0 8%
IB 16.3 11.5 13.3 12.8 12.5 12.6 -6%
Centre 0.2 0.0 0.0 0.1 0.1 0.1 nm
Total 30.4 24.4 25.7 25.6 25.5 25.9 1%
Implied Revenue per FTE
CHFm 2010 2011 2012e 2013e 2014e 2015e 2015e/2012
WM 0.49 0.44 0.44 0.46 0.47 0.48 11%
R&C/CIC 0.36 0.36 0.39 0.40 0.39 0.40 4%
AM 0.77 0.77 0.69 0.72 0.76 0.85 23%
IB 0.81 0.55 0.64 0.64 0.64 0.65 1%
Centre nm nm nm nm nm nm nm
Total 0.62 0.49 0.52 0.54 0.54 0.55 6%
Source: Liberum Capital
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
17/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 17
Relatively poor cost and RWA disclosure for CS
In analysing the differences in costs and revenues between CS and UBS, its
notable that CS doesnt provide staff costs (or RWA detail) for the WM and CIC
divisions within private banking. We have estimated the numbers to facilitate the
analysis.
The IB divisions of both CS and UBS destroy economicvalue after fully loading divisions for cost savings,central costs, below the line items, and regulation
In terms of presentation, both UBS and particularly CS flatter their divisionalresults by accumulating significant costs at the corporate centre and below
the PBT line. Any meaningful sum of the parts (SoTP) valuation methodology
has to allocate these centralised costs which are often at least partially ignored.
In addition, a SoTP valuation should reflect the impact of regulation such asDodd Frank (negative for derivatives revenues as standardised derivatives move
from relatively wide spread OTC trading to more transparent low margin
exchange trading) and ring fencing (increased funding costs due to reduced
implicit tax payer support) which will occur just beyond the explicitly
forecasted earnings time horizon but clearly still impact valuation.
In light of the above, we calculate 2013e fully adjusted divisional attributable
earnings and RoB3E for UBS and CS.
Since non equity minority interest charges relate to non equity regulatory capital,
they are allocated in proportion to Basel 3 RWAs. We also allocate central costs in
proportion to RWAs since these costs are largely proportional to balance sheet
usage. We also allocate approximately half of the forecasted cost savings by 2015e
to generate a more accurate normalised earnings run-rate for each division in
2013e- effectively estimating a fully normalised 2014e run-rate for attributable
earnings.
As figure 26 illustrates, for UBS the capital adjusted Group return on Basel 3 equity
(RoB3E) improves slightly to 22.4% on a fully loaded basis (due to cost savings)
from 20.4% unloaded, however the divisional RoB3Es decline. The investment bank
RoB3E declines to 5.5% (from 8.9%). On these numbers, shutting the UBS IB
division entirely would be value accretive for UBS (about CHF3.3bn of fair value
CHF0.9 per share before shutdown costs). However, arguably, profitability in the
wealth management and R&C divisions probably depend to some extent on the IB
depending on transfer pricing although UBS maintains all inter divisional
transactions are arms-length implying UBS could realistically close its IB without
impacting the earnings of its other divisions.
Relatively poor disclosure on staff
costs and RWAs from CS for the
Corporate and Institutional division
compared with UBSs for the Retail
and Corporate division
Both UBS and CS flatter their
divisional RoB3Es by shiftingexpenses and RWAs to the
corporate centre and by having
expenses below the line such as
preference share dividends and
earnings for unvested equity.
Shutting UBSs IB entirely would
be value accretive by about
CHF0.9 per share
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
18/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
18 www.liberumcapital.com
Figure 26: UBS 2013e fully loaded divisional returns on Basel 3 equity at 10% Basel 3 equity gearing
CHF bn YE13
Basel 3RWAs
Capital
gearing
Capital U/L PBT Attri b
utableearnings
Unloaded
RoB3E
Reallocate
centrecapital
Adjusted
Allocatedcapital
Reallocate
centralcost,
minoritiesetc
Regulatory
impact*
Cost
saves*
Fully
loadedattrib
earnings
Loaded
RoB3E
Wealth Mgmt 19.3 10% 1.9 2.8 2.2 112.1% 0.1 2.0 -0.1 0.0 0.1 2.2 107.8%
Retail & Corporate 40.2 10% 4.0 1.8 1.4 34.7% 0.1 4.2 -0.3 0.0 0.1 1.2 28.3%
GAM 3.6 10% 0.4 0.6 0.5 134.5% 0.0 0.4 0.0 0.0 0.0 0.5 123.1%
Investment Bank 70.0 10% 7.00 0.8 0.6 8.9% 0.2 7.2 -0.5 -0.2 0.4 0.4 5.5%
Wealth Mgmt USA 26.4 10% 2.6 1.1 0.9 32.7% 0.1 2.7 -0.2 0.0 0.0 0.7 24.9%
Centre & MI** ex legacy 5.7 10% 0.6 -1.4 -1.1 -195.4% -0.6 - 1.1 0.0 0.0 0.0 nm
Legacy runoff 60.8 10% 6.1 0.2 0.2 3.0% - 6.1 0.0 0.0 0.0 0.2 3.0%
Subtotal 225.9 10% 22.6 5.9 4.6 20.4% 0.0 22.6 0.0 -0.2 0.6 5.1 22.4%
Excess capital - 2.5 0.0 0.0 1.0% - 2.5 0 0 0 0.0 1.0%
Total 225.9 25.1 5.9 4.6 18.4% - 25.1 0.0 -0.2 0.6 5.1 20.2%
*Net tax ; **MI: Equity minorities interest chargeSource: Company Reports; Liberum Capital
For CS, the fully loaded RoB3E declines to 13.0% vs. 13.8% as the regulatory
impact of minus CHF0.5bn exceeds forecasted savings of CHF0.3bn.
Figure 27: CS 2013e fully loaded divisional returns on Basel 3 equity at 10% Basel 3 equity gearing
CHF bn YE13eBasel 3RWAs
Capitalgearing
AllocatedCapital
U/LPBT
Attrib utable
earnings
UnloadedRoB3E
Reallocatecentrecapital
AdjustedAllocated
capital
Reallocatecentral
cost,minorities
etc
Regulatoryimpact*
Costsaves*
Fullyloaded
attribearnings
LoadedRoB3E
Wealth Mgmt 24.0 10% 2.4 2.5 1.9 77.6% 0.1 2.5 -0.1 0.0 0.0 1.8 70.0%
Corp and Institutions 48.7 10% 4.9 0.9 0.7 14.2% 0.2 5.1 -0.2 0.0 0.0 0.5 9.3%
Asset management 12.6 10% 1.3 0.5 0.4 27.8% 0.1 1.3 0.0 0.0 0.1 0.4 28.7%
Investment Bank 180.0 10% 18.0 2.6 2.0 10.9% 0.8 18.8 -0.71 -0.5 0.2 1.0 5.2%
Centre & BTL** 12.0 10% 1.2 -1.2 -1.0 -86.8% -1.2 - 1.0 0.0 0.0 0 nm
Subtotal 277.4 10% 27.7 5.2 3.8 13.8% 0.0 27.7 0.0 -0.5 0.3 3.6 13.0%
Excess capital - 0.5 0.0 0.0 1.0% 0 0 0 0.0 1.0%
Total 277.4 28.3 5.3 3.8 13.6% 0.0 -0.5 0.3 3.8 12.7%
*Net tax; **BTL: Below the Line
Source: Liberum Capital
For CS, the loaded IB RoB3E of 5.2% implies the IB is destroying economic value.
On these estimates, shutting Credit Suisses IB division would boost Group fair
value by cCHF9.7bn (CHF6.1 per share). Net of shutdown costs we estimate
restructuring or closing the IB could generate value in the range CHF 1.9-3.0 /share
(8-15% of current share price)
Basel 3 capital calculation YE13 (for valuation
purposes): small surplus for both UBS and CS Libor risk: Our CS and UBS capital calculation used for valuation applies a
CHF1.5bn capital deduction to reflect potential LIBOR fines (for CS, UBS has
already incurred CHF1.4bn in fines and disgorgement) and litigation risk (both
UBS and CS) although CS is on only 3 Libor setting panels (USD, CHF and
EUR) and therefore is arguably less exposed than for example BARC which is on
at least 10 of the major LIBOR panels.
Our capital calculation implies a YE13e CHF2.5bn surplus for UBS andCHF0.5bn for CS relative to our assumed 10% imposed capital ratio target used
for valuation.
Although UBS will in reality will operate with a Basel 3 equity tier 1 in excess of13.0%, our valuation methodology assumes that the excess capital relative to
On a fully attributed basis and after
including future costs for regulatory
changes and also future efficiency
savings the implied IB RoB3E for
UBS and CS are 5.5% and 5.2%
respectively.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
19/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 19
peers will be manifested in a lower cost of equity essentially viewing UBS as
operating with excess capital equivalent of c3% of RWAs or approximately
CHF6bn.
Figure 28: YE13e Basel 3 equity position fully loadedCHF UBS CS
Tier 1 capital 41.8 48.0
Hybrids and Pref shares -4.3 -8.9
Basel II Core Tier 1 (LIB Defn) 37.4 39.1
Deduct Minorities 0 -3.2
Include AFS reserves 0 0.0
Deferred tax -4.8 -5.4
Shortfall in provisions vs. exp. losses 0.0 0.0
Pension -3.8 0.0
Reverse securitis. deductions 50% 0.6 0.0
Impact Libor fines/ litigation -1.5 -1.5
Add back Basel 2 Fin Investments 0 0.0
Other -2.9 -0.7
B3 CET1 pre fin invest deductions 25.1 28.2Financial Investments 0 0
Max recognisable Fin Investments 2.5 2.8
Deduction of Fin Investments 0.0 0.0
Basel III equity tier 1 25.1 28.2
Basel 2.5 RWAs 163.3 239.6
CVA RWA increase n/a 92.6
Securitisation gross up n/a 0.0
Mgmt mitigation n/a -55.0
Basel III RWAs 225.9 277.2
Basel II Core Tier 1 22.9% 16.3%
Basel I II Equity T ier 1 inc luding Libor f ine and l it igat ion costs 11.1% 10.2%
Bus mix required capital estimate 10.0% 10.0%
Surplus capital 1.1% 0.2%
Surplus 2.5 0.5
Source: Company Reports; Liberum Capital
SoTPs Valuation: 20% upside for UBS; 2% for CS
UBSs increased capital discipline implies re-rating: UBSs clear intention tocapital ration its value-destroying IB division to a maximum of CHF70bn in RWAs
increases the SoTP value of its other businesses in our view since more of the
value created is likely to reach shareholders justifying our 14.0x multiple for
Wealth Management and Asset Management earnings
CSs ongoing IB ambitions imply a 12% PE multiple discount to 12.5x (vs. UBS14.0x) for the Wealth Management and Asset Management divisions given the
likelihood/risk that free cash flow is diverted to the IB.
Figure 29 shows the capital and regulation adjusted sum of the parts valuationfor UBS. The Attributable earnings are taken from figure 26 while the YE13e
capital position is from Figure 28. The YE13e value per share is calculated and
then discounted to the present (10 months). We also add the 2012e announced
dividend paid in May 2013 as well as the announced 2013e dividend since its
deducted from the YE13e capital position. All central and below the line earnings
are allocated by division as well as capital held in the central division.
The YE13e fully loaded basel 3
capital level vs. a 10% target is a
key input to our SoTPS valuation.
We make a further adjustment to
the fully loaded Basel 3 capital
ratio of CHF1.5bn for both UBS
and CS to reflect incremental costs
related to Libor rigging both fines
and litigation risk.
UBS has lower risk of Wealth
management and asset
management cash flow being
malinvested in the IB (due to
smaller size and management
commitment to a max of CHF70bn
in IB RWAs). Therefore we
assume UBSs WealthManagement and Asset
Businesses merit a higher multiple
of 14.0x in the SoTPs vs. 12.5x for
CSs equivalent businesses.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
20/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
20 www.liberumcapital.com
For UBS we also apply a normalised tax rate of 22% (vs. the reported 15%or lower) and separately add the PV of UBSs unrecognised potential
deferred tax assets see figure 34.
Figure 29: UBS Sum of the Parts calculated at YE13e and discounted to present valueCHFbn Per Share
YE13e Basel 3
EquityCapital
required
Clean
attributable earnings
PE Clean
YE13eValue
Cost to
achieve*
Un-
recognisedUPDTA
YE13
value
PV Basel 3
EquityCapital
required
Clean
attributableearnings
Clean
YE13eValue
Re-
struccosts
Un- recog-
nised DTA
Present
Value/Share
Wealth Mgmt Swiss 2.0 2.2 14.0 30.1 0.0 0.5 30.6 28.4 0.5 0.6 7.9 0.0 0.1 7.5
Wealth Mgmt America 2.7 0.7 14.0 9.5 0.0 5.4 14.9 13.9 0.7 0.2 2.5 0.0 1.4 3.7
Wealth Mgmt combined 4.7 2.8 14.0 39.5 0.0 5.9 45.5 42.3 1.2 0.7 10.4 0.0 1.6 11.1
Retail & Corpor ate/ CIC 4.2 1.2 10.0 11.8 0.0 0 11.8 11.0 1.1 0.3 3.1 0.0 0.0 2.9
Asset Management 0.4 0.5 14.0 6.4 0.0 0.0 6.4 6.0 0.1 0.1 1.7 0.0 0.0 1.6
Investment Banking 7.2 0.4 9.0 3.6 0.0 1.6 5.2 4.8 1.9 0.1 1.0 0.0 0.4 1.3
Core total 16.5 4.9 12.6 61.4 0.0 7.5 68.9 64.2 4.4 1.3 16.2 0.0 2.0 16.9
Legacy 6.1 0.2 4.1 4.3 -3.5 0.0 0.7 0.7 1.6 0.0 1.1 -0.9 0.0 0.2
Surplus/deficit (+/-) 2.5 0.0 2.5 0.0 2.5 2.3 0.7 0.0 0.7 0.0 0.0 0.6
Total 25.1 5.1 13.4 68.2 -3.5 7.5 72.2 67.2 6.6 1.3 18.0 -0.9 2.0 17.7Dividends 12-13e 1.2 0.3
Fair value 68.4 18.0
Current market value 56.9 15.0
Implied upside 20% 20%
# shares bn 3.80
Ke 9%
time (years) 0.8
Current share price 15.00
*Cost to achieve: restructuring costs after YE13e and hence not reflected in YE13e equity capital
Source: Liberum Capital
UBS SoTPs value by division: the Wealth and asset management business willaccount for 68% of UBSs 2013e earnings and 75% of fair value in our SoTP
(before considering unrecognised DTAs). The IB accounts for 32% of capital but
only 5% of group value.
CS SoTPs value by division: the Wealth Management businesses account for66% of value and 59% of earnings. The IB accounts for 68% of capital but only
22% of value.
Figure 30: Credit Suisse Sum of the Parts calculated at YE13e and discounted to present value
CHF bn Per share
YE13e Basel 3EquityCapital
required
Adjustedattributable
earnings
YE13ePE
CleanYE13eValue
Costs toachieve*
YE13value
PresentValue
Basel 3EquityCapital
required
Adjustedattributable
earnings
PE CleanYE13eValue
Coststo
achieve
YE13value
PresentValue
/Share
Wealth Mgmt. 2.5 1.8 12.5x 22.0 0.0 21.9 20.4 1.6 1.10 12.5x 13.7 0.0 13.1 12.7
Retail & Corp/ CIC 5.1 0.5 10.0x 4.7 -0.1 4.7 4.3 3.2 0.30 10.0x 3.0 0.0 3.2 2.7
Asset Management 1.3 0.4 12.5x 4.7 0.0 4.7 4.4 0.8 0.24 12.5x 3.0 0.0 2.8 2.7
Investment Banking 18.8 1.0 9.0x 8.9 -0.3 8.6 8.0 11.8 0.62 9.0x 5.5 -0.2 5.1 5.0
Total core 27.7 3.6 11.2x 40.3 -0.4 39.9 37.0 17.3 2.25 11.2x 25.2 -0.2 24.2 23.2
Surplus/deficit (+/-) 0.5 0.5 0.0 0.5 0.5 0.3 0.00 0.3 0.0 0.3 0.3
Total 28.3 3.6 11.4x 40.9 -0.4 40.5 37.6 17.7 2.25 11.4x 25.6 -0.2 25.3 23.5
Dividends 12-13e 2.4 1.5
Fair Value 40.0 25.0
Current Market value 39.0 24.4
Implied upside 2% 2%
# shares bn 1.60
Ke 9%
time (years) 0.8Current share price 24.4
*Cost to achieve: restructuring costs after YE13e and hence not reflected in YE13e equity capital
Source: Liberum Capital
For UBS we include CHF2.0 per
share of value for unrecognised
potential deferred tax assets, whilenormalising the tax charge to 22%
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
21/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 21
UBS has a fair value per share of CHF18.0, 20% upside. CS has a fair valueper share of CHF25.0, 2% upside.
PE multiples for selected WM peers: As a rough cross check for the 14.0x
multiple applied to wealth management and asset management for UBS, figure31 shows the current PEx Julius Baer and Blackrock. While a highly limited
sample, the current average multiple of 15.5x suggests our 14.0x multiple is not
unreasonably high.
Figure 31: Current PE multiples for Julius Baer and Blackrock
10.00
11.00
12.00
13.00
14.00
15.00
16.00
17.00
18.00
Jan-11
Mar-11
May-11
Jul-11
Sep-11
Nov-11
Jan-12
Mar-12
May-12
Jul-12
Sep-12
Nov-12
Jan-13
BAER BLK Avg
*PEx calculate using Bloomberg consensus for next 12 month Rolling EPS and grossing up by 4% to estimate current PESource: Bloomberg
Wealth management peers trade
on c15.5x current consensus
earnings
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
22/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
22 www.liberumcapital.com
BUY
UBSAddition by SubtractionPRICE: 15.0 | SWITZERLAND | BANKS | UBSN.VX | UBSN VX
In contrast to Credit Suisse, UBS has committed to radically
downsizing its FICC business with cuts in IB RWAs of 57% and cuts
in IB headcount of 42%. A dividend yield of 9.5-11.9% looks feasible
2015-17e. Our Sum of the Parts implies 20% upside, with the WM
businesses on a PE of 14.0x vs. WM peers on 15x. BUY.
Improving cost efficiency: Analysis of costs per employee bydivision shows that UBS is on track to achieve a CHF3bn reduction in
operating expenses by 2015e via headcount reduction of 10,000 of
which we estimate 7,000 will be in the investment bank. On that basis
we believe a Group cost income ratio of 72% is feasible by 2015 vs.
81% in 2012e, and still above Managements target range of 60-70%.
Significant capital release 9.5+% dividend yield by 2015e: FromYE12e-YE15e, UBS will reduce its Basel 3 RWAs by CHF 66bn
releasing 8.6bn of capital (at a 13% equity ratio) while also achieving
statutory earnings of CHF 10.1bn implying aggregate capital release
of CHF18.7bn - equivalent to 33% of the current market cap. We
expect UBS will exceed the 13.0% Basel 3 target by YE14e implying
increased capital distributions from 2015 onwards- equiv. to a c9-10%
yield while further increasing its Basel 3 equity to 15.8% by YE17e.
Unrecognised Potential Deferred Tax Assets (UPDTAs) ofCHF24.6bn with an est. present value of CHF7.5bn equivalent to 13%
of the current market cap. Our SoTPS assumes a normalised 22% tax
rate and adds the CHF7.5bn separately (note: CS has no UPDTAs).
UBSs 4Q12 profit warning offset by accelerated balance sheetshrinkage: The statement on 19
thDec guided to a CHF2.0-2.5bn
4Q12 attributable loss mainly due to Libor-rigging fines. However the
Basel 3 equity capital ratio stayed at c9.3% implying a cCHF35bnshrinkage in RWAs thereby broadly offsetting the valuation impact and
suggesting that UBS may reach the targeted CHF200bn of Basel 3
RWAs well ahead of the YE17e guidance.
UBS looks optically expensive on basic valuation metrics: 2013ePE 12.3x for p/TCE of 1.2x for RoTCE 10.9%; yielding 1.3% (UK
banks PE only 10.6x).
..but UBS is cheap on an adjusted basis: Adjusted for capital,regulation, UPDTAs and ex legacy assets, UBS trades on 2013e PE
10.0x; p/TCE 1.2x for RoTCE of 13.2% implying good relative
value. Our capital and regulation adjusted SoTPs target price of
CHF18.00 implies 20% upside. BUY.
Stock Data
Target Price (CHF) 18.00
52-Week Range (CHF) 9.69 - 15.62
Current price (CHF) 15.00
Shares Outstanding (bn) 3.75
Free Float (%) 91%Market Cap (CHF bn) 56.2
Avg daily volume (m) 11
*E=Liberum Capital Estimates
Stock Performance
7.0
9.0
11.0
13.0
15.0
17.0
Jan-12 Mar-12 Jun-12 Sep-12 Dec-12
UBS EURO Banks
Price Performance 1M 3M 12M
Price 15.0 12.0 11.1
Absolute 0% 25% 35%
Rel SMI -2% 19% 18%
Rel Eurobanks -6% 13% 1%Source: Bloomberg
Summary Financials & Valuation
Dec y/e (CHF bn) FY11A FY12E FY13E FY14ERevenue 29.8 25.6 27.5 27.4
Op Costs -22.4 -27.7 -21.2 -20.3
Impairments -0.1 -0.1 -0.1 -0.1
PBT 7.3 -2.3 6.3 7.0
Adj EPS, CHF 1.11 0.99 1.22 1.38
P/Adj EPS 13.6 15.1 12.3 10.9
DPS, CHF 0.1 0.2 0.2 0.5
Yield % 0.7 1.0 1.3 3.3
TCE/share, CHF 11.4 11.4 11.9 12.5
RoTCE % 10.5% 8.7% 10.4% 11.3%
P/TCE 1.31 1.31 1.26 1.20
Basel 3 RWAs 380.0 266.0 225.9 210.9
B3CET1* reportd (%) 10.7% 13.6% 17.8% 20.8%B3CET1* full load (%) 6.7% 9.3% 11.8% 13.6%Source: Liberum Capital estimates
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
23/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 23
UBSValuing UBS is relatively complex given that i) the group has a diverse group
of businesses ii) is currently undergoing a radical restructuring iii) has hidden
value due to Unrecognised Potential Deferred Tax Assets (UPDTAs).
We address the business mix via a sum of the parts approach see main sectionFigure 29. i) The restructuring is outlined below followed by ii) our estimate of the
present value of the UPDTAs iii) some comment on the 4Q12 profit warning
related to the libor rigging fines and iv) some brief commentary on the divisional
outlooks.
i) Summary of UBS restructuring plans: shrinkingbalance sheet, capital consumption and headcount
By way of background context, UBS plans to
Shrink its group funded balance sheet by 30% to CHF600bn by YE15e.
Reduce Basel 3 RWAs by 1/3rd
: from CHF301bn to below CHF 250bn
by YE13e and below CHF 200bn by YE17
Reduce headcount by 10,000 to 54,000 (-16%) with majority of the cuts
in the investment bank division. We estimate investment bank headcount
will decline from 16,500 at YE12e to 9,500 by YE15e (-42%).
Reduce operating costs by a further CHF4bn from the 9M12 annualised
run rate, CHF2.5bn net of CHF1.5bn in planned increased investment. Our
own forecasts assume net cost cuts of CHF3.0bn by YE15e to
CHF19.5bn, a 13% decline, forecasting curtailed investment due to weaker
than expected revenues- we are CHF1.1bn below consensus on 2015e
revenues and 9% below consensus EPS.
Exit FICC2
businesses within credit and rates which are unlikely to beat
their cost of capital under the new Basel 3 regulatory framework.
As a consequence of this restructuring, UBS guides that the reported Group RoE will
be in the 3-7% range in 2013 and 2014e implying annual 1-off restructuring costs of
CHF3.5bn (assuming a c 5% reported RoE) relating to redundancy payments,
losses on asset disposals etc. We factor this into our valuation (2013e impact
included in YE13e capital and 2014/15 impact included in SoTPs separately net oftax).
Smaller UBS balance sheet implies lower regulatory risk for UBS: The planned
shrinkage of UBS funded balance sheet from CHF900bn to CHF600bn by 2015e
will significantly reduce the valuation impact of any increase in RWA/Asset due to
revised regulatory guidance on RWA calculation e.g. moving to standardised
RWAs. This represents a key advantage vs. Credit Suisse in our view which will
operate with CHF300bn of RWAs (vs. UBSs CHF200bn).
UBS Cap-adjusted RoB3E rises to 26.0% by 2015e: As a consequence of these
changes we estimate that by 2015e, adjusted for regulation and after allocating
2 FICC: Fixed Income Currency and Commodities
UBS has committed to closing
many of its least profit IB
businesses thereby boostingeconomic profit for Shareholders
and more than doubling returns on
regulatory equity capital
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
24/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
24 www.liberumcapital.com
capital at 10% of Basel 3 RWAs, UBS will achieve an underlying return on Basel 3
equity capital (RoB3E) of 26.0% up from 11.2% in 2012e; rising further to 30.3% in
2017e due to further capital shrinkage under conservative operational leverage
assumptions within the wealth management businesses.
Of course on an actual reported basis returns will be more lacklustre due to the
groups intention to operate at a 13% Basel 3 equity capital ratio, or higher, rather
than the 10% gearing discussed above. In addition looking at profitability in terms of
RoTCE further depresses returns due to several items included within equity (see
figure 8). So the underlying RoTCE without adjusting for capital will increase
only modestly from 8.7% in 2012e to 11.6% in 2017e.
In our base case, by 2017e, UBS will have a Basel 3 equity capital ratio of15.8%, implying a CHF11.2bn capital surplus vs. our 10% requirement.
Critical to our BUY investment case, is the assumption that equity investors will
take account of UBSs excess capital in the valuation and will assess its capital
position relative to international norms (we assume a 10% target) rather than
relative to UBSs own 13% target capital run rate.
The primary risk to our Buy case is the risk that UBS loses capital discipline onceit becomes highly cash-flow positive. We anticipate the tendency to expand the
business via M&A or via RWAs credit growth will be considerable which could
jeopardise our attractive dividend projections.
For sake of comparison, UBSs restructuring of its IB is more radical thanthe substantial changes made by RBS with RWAs down -57% vs. 31% for
RBS and Staff levels down 42% vs. 25% for RBS.
Figure 32: RWAs Pre and Post IBrestructuring, reporting CCY bn
Figure 33: IB Headcount Pre and Post IBrestructuring, 000s
0
50
100
150
200
RBS UBS
Before After
0
5
10
15
20
RBS UBS
Before After
Source: Liberum , Company reports Source: Liberum , Company reports
ii) Off balance sheet UPDTAs worth CHF7.5bnUBS has large Unrecognised Potential Deferred Tax Assets (UPDTAs) of
CHF24.6bn (3Q12), 43% of market cap, generated as a result of net operating
losses incurred during the 2007-2008 financial crisis. While not all of the UPDTAs
are likely to be successfully utilised before expiration, we estimate that CHF 14.7bn,
c60%, will be utilised. We estimate a present value for these of CHF7.5bn, or CHF2
per share, equivalent to 13% of current market cap.
Credit Suisse investor has no UPDTAs according to their investor relationsteam making this an often overlooked relative valuation factor in UBSs
favour.
UBSs IB restructuring is more
aggressive than that of RBS
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
25/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 25
Under the IAS 12 accounting standards, deferred tax assets (DTAs) can only be
recognised against probable future profits. UBS uses a 5 year time horizon for
recognition. Without unrecognised DTAs, UBS would have a normalised tax rate in
the range 20-25%. Our Sum of the parts assumes a 22% tax rate and then adds
the CHF7.5bn present value of the UPDTAs. Over 2010 and 2011, recognisingmore DTAs enabled UBS to pay an average tax rate of only 6.1% resulting in a per
annum boost to attributable earnings of c CHF1bn.
Figure 34 summarises our valuation of the UPDTAs: In the US the averageremaining life of the CHF18.8bn of UPDTAs is 16 years as of 3Q12. We estimate
the remaining life in Switzerland is 3 years (given a 7 year time limit and an
assumed 2008 inception). In the UK there is no time limit on utilisation. We apply
a relatively high discount rate in the US of 7.5% to reflect the constrained time
limit. By contrast in the UK, with no time limit on utilisation we apply a discount
rate of 3%. For the smaller RoW (rest of world) amounts of CHF 0.8bn we use a
higher 10% discount rate to reflect lack of information/uncertainty.
Figure 34: Estimating value of UBS Unrecognised Potential Deferred Tax Assets
CHF bn Unrecognised potential
DTAs
Relevantannual PBT
2014e
Tax rate Annualrelevant
payable tax
EstimatedAmountutilisedbefore
expiration
Amountutilised preexpiration
Est. date offull
utilisation
Remaininglife
Assumeddiscount
rate
PV ofunrecognise
d DTAs
PV/ MaxPotential
DTAs
Value pershare
US 18.8 1.4 35% 0.5 11.2 59% 2028 16 8% 5.1 27% 1.3
Switzerland 2.4 4.8 20% 1.0 0.5 22% 2015 3 2% 0.5 21% 0.1
UK 2.6 0.4 21% 0.1 2.63 101% 2039 Unlimited 3% 1.6 61% 0.4
RoW 0.8 1 22% 0.2 0.4 50% 2020 n/a 10% 0.3 42% 0.1
Total 24.6 7.6 23% 1.7 14.7 60% 7.5 31% 2.0
Source: Liberum Capital
By way of illustration we show the more detailed workings for the largest,CHF18.8n, of US Unrecognised Potential Deferred Tax Assets: Beyond the
current 5 year measurement horizon which have already translated into on-
balance sheet DTAs (albeit at conservative levels), we estimate US taxable
earnings of CHF1.9bn (mainly from Wealth Management America but also the
IB) from 2018e, growing at 4% per annum.
In addition, prior to 2018e, we also consider the incremental PBT relative tothe current balance sheet DTA measurement assumptions. We understand
from previous CFO guidance (John Cryan) that the DTA measurement process is
highly conservative- taking substantial discounts to the actual management
business plan. On that basis, we assume that there will be incremental US
taxable annual earnings of CHF0.2-0.3bn within the current 5 year time horizon.
Discounting all the savings at 7.5% gives us a present value of CHF5.8bn for the
CHF18.8bn of US UPDTAs. An area of further investigation would be to what
extent UBS could utilise more of these US UPDTAs by enhancing US taxable via
M&A, incremental investment in its US franchise or other restructuring.
Due to large historical losses UBS
has more potential deferred tax
assets than it can recognise under
conservative accounting
standards. We estimate a PV of
CHF7.5bn for the off balance
potential deferred tax assets
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
26/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
26 www.liberumcapital.com
Figure 35: Estimating present value of Unrecognised potential DTAs in United States
Years FWD Fin Yr Discount factor Assumed taxable earnings Tax saving PV @7% discount rate
1 2013e 0.93 0.2 0.1 0.07
2 2014e 0.87 0.3 0.1 0.09
3 2015e 0.80 0.3 0.1 0.08
4 2016e 0.75 0.3 0.1 0.085 2017e 0.70 0.3 0.1 0.07
6 2018e 0.65 1.9 0.7 0.44
7 2019e 0.60 2.1 0.7 0.44
8 2020e 0.56 2.2 0.8 0.43
9 2021e 0.52 2.4 0.8 0.43
10 2022e 0.49 2.5 0.9 0.43
11 2023e 0.45 2.7 1.0 0.43
12 2024e 0.42 2.9 1.0 0.43
13 2025e 0.39 3.1 1.1 0.42
14 2026e 0.36 3.3 1.2 0.42
15 2027e 0.34 3.6 1.2 0.42
16 2028e 0.31 3.8 1.3 0.42
Total utilised 32.0 11.2 5.1
Unrecognised potential DTAs 18.8
Assumed % utilised 59%
Source: Company Reports; Liberum Capital
iii) 4Q12 profit warning related to the Libor Riggingfines offset by higher than expected RWA shrinkage
On 19Dec12, UBS announced an agreement to pay CHF1.4bn in fines anddisgorgement (of illegal profits) to US, UK and Swiss authorities. We
estimate reported 4Q12 PBT of minus CHF2bn, as a result of this fine (not tax
deductible) as well as other litigation provisions of CHF0.7bn, restructuring costs
of CHF0.5bn as well as fair value own debt losses CHF0.4bn (due to tighteningcredit spreads).
Excluding these items we estimate underlying 4Q12 PBT of positive CHF993mimplying an underlying adjusted EPS for full year 2012e of CHF0.99 after
normalising the tax rate to 22% and excluding STAB option gains of CHF337m in
9M12.
Unchanged capital adequacy despite 4Q12 reported attributable loss ofCHF 2.25bn: The UBS statement referred to a roughly unchanged fully Basel 3
equity tier 1 in 4Q12 vs. the reported 9.3% 3Q12 level. Assuming a 9.3% ratio at
end 4Q12 which implies a significant 4Q12 drop in Basel 3 RWAs of CHF35bn.
Accelerated restructuring: Based on the implied 4Q12 RWA shrinkage weexpect that UBSs balance sheet shrinkage will occur faster than 3Q12 guidance
with positive implications for capital release and dividends
iv) Group and Divisional P&L trends
Underlying EPS trend: We expect 23% and 13% underlying EPS growth toCHF1.22 and CHF1.38 in 2013e and 2014e respectively primarily driven by
strong PBT growth in the wealth and asset management divisions. We are 3%
above Bloomberg adjusted consensus in 2014e- see figure 5- (however
Bloomberg consensus has considerable noise with some estimates apparentlyincluding restructuring costs, where as we have excluded CHF3.5bn of 1-off
costs in 2013e and 2014e from adj. EPS so its likely in our view that underlying
consensus is considerably above the Bloomberg reported levels)
To the extent UBS can boost its
US pre tax earnings, it will be able
to maximise its CHF18.8bn of US
UPDTAs which we value currently
at CHF5.1bn
We estimate UBSs RWAs
declined by CHF35bn in 4Q12
which could indicate faster than
expected capital release going
forward.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
27/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 27
Figure 36: UBS summary divisional PBT-underlying
% Ch
CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012 2013 2014 2015 2016 2017
Wealth Mgmt 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%
Retail & Commercial 1.7 1.6 1.8 1.8 1.8 1.8 1.7 -6% -3% 12% 0% -1% 0% -3%
Global Asset Management 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%Investment Bank 1.1 0.9 0.8 1.0 1.0 1.0 1.1 -49% -15% -15% 29% 0% 1% 1%
Wealth Management USA 0.5 0.8 1.1 1.3 1.3 1.4 1.5 86% 75% 32% 14% 6% 6% 3%
Centre Core -0.2 -0.9 -0.8 -0.7 -0.6 -0.5 -0.5 -12% -15% -17% -11% -11%
Total Underlying PBT ex legacy 5.8 5.2 6.3 7.0 7.4 7.8 8.1 -19% -10% 20% 13% 5% 5% 4%
Corporate centre legacy assets 0.0 0.0 -3.5 -3.5 -1.0 0.0 0.0
Total U/L PBT 5.8 5.2 2.8 3.5 6.4 7.8 8.1 -19% -10% -47% 29% 81% 21% 4%
1-offs -0.4 -7.5 0.0 0.0 0.0 0.0 0.0
Reported PBT 5.4 -2.3 2.8 3.5 6.4 7.8 8.1
Group MI s -0.3 -0.3 -0.3 -0.3 -0.3 -0.3 -0.3
U/L Attributable 4.2 3.8 4.6 5.2 5.5 5.8 6.0
EPS 1.11 0.99 1.22 1.38 1.45 1.53 1.59 -19% -11% 23% 13% 5% 5% 4%
Basel 3 RWAs 380 266 226 211 200 192 195
U/L Ro B3E at 10% CT1 11.2% 11.7% 18.8% 24.0% 26.9% 29.6% 31.2%
Source: Liberum Capital
At a group P&L level we expect broadly flat revenues in 2012-2014e withdeclines in investment banking revenues broadly offset by increases in the
wealth and asset management divisions.
Group expenses: We forecast a CHF3bn decline in expenses by 2015e vs.2012e slightly ahead of the guided net of CHF2.5bn (CHF4bn of reductions and
CHF 1.5bn of investment spend) as we are relatively pessimistic on the revenue
outlook vs. consensus and we suspect management plans.
Figure 37: UBS Group P&L- underlying
% Ch
CHF bn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e
Revenues 27.9 27.9 27.5 27.4 27.0 27.8 28.5 -10% 0% -1% 0% -1% 3% 3%
Total expenses -22.0 -22.5 -21.2 -20.3 -19.5 -19.9 -20.4 -8% 2% -6% -4% -4% 2% 2%
PIP 5.9 5.4 6.3 7.1 7.5 7.9 8.1 -18% -9% 18% 13% 5% 5% 4%
Loan losses -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1
PBT (ex legacy) 5.8 5.2 6.3 7.0 7.4 7.8 8.1 -18% -10% 20% 13% 5% 5% 4%
1.3 0.9 0.8
Rev 1-offs 1.9 -2.3 0.0 0.0 0.0 0.0 0.0
Cost 1-offs -0.4 -5.2 0.0 0.0 0.0 0.0 0.0
1-offs 1.5 -7.5 0.0 0.0 0.0 0.0 0.0
PBT (ex legacy) 7.3 -2.3 6.3 7.0 7.4 7.8 8.1
U/L Attributable 4.2 3.8 4.6 5.3 5.5 5.8 6.0 -19% -11% 22% 13% 5% 5% 4%
Cost Income 79% 81% 77% 74% 72% 72% 71%
Basel 3 RWAs 380 266 226 211 200 192 195 0% -30% -15% -7% -5% -4% 1%
U/L Ro B3E at 10% CT1 11.2% 11.7% 18.8% 24.0% 26.9% 29.6% 31.2%
Source: Liberum Capital
In wealth management we conservatively assume just 3.0% asset performancein 2013e (despite equity markets strong start YTD of 3-4%) and 2% in
subsequent years (which includes reinvested dividends and coupons) and also
conservatively assume net new money growth of only CHF25bn per annum (c3%
of invested assets) down from CHF30bn in 2012e.
We assume ongoing margin erosion down to 85bps vs. 2012e 90bps due to theongoing low yield environment and subdued client activity.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
28/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
28 www.liberumcapital.com
We assume relatively tight cost control with the cost income ratio towards thebottom end of managements guided range of 60-70%.
Figure 38: UBS Wealth Management Division Underlying
% Ch
CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e
Revenues 7.2 7.1 7.4 7.8 8.0 8.4 8.8 -2% -1% 4% 4% 4% 5% 5%
Staff cost -3.3 -2.9 -2.9 -2.9 -3.0 -3.1 -3.3 3% -12% 1% 2% 3% 4% 4%
Other expenses -1.6 -2.0 -1.8 -1.8 -1.9 -1.9 -2.0 -9% 22% -11% 2% 3% 4% 4%
Total expenses -4.9 -4.8 -4.7 -4.8 -4.9 -5.1 -5.3 -2% -1% -4% 2% 3% 4% 4%
PIP 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%
Loan losses 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Underlying PBT 2.3 2.3 2.8 3.0 3.1 3.3 3.5 -3% -2% 22% 8% 5% 6% 6%
Rev 1-offs 0.4 0.0 0.0 0.0 0.0 0.0 0.0
Cost 1-offs -0.1 0.2 0.0 0.0 0.0 0.0 0.0
1-offs 0.4 0.2 0.0 0.0 0.0 0.0 0.0
Reported PBT 2.7 2.5 2.8 3.0 3.1 3.3 3.5
PAT 1.8 1.8 2.2 2.3 2.4 2.6 2.7
Underlying attributable 1.7 1.6 2.0 2.1 2.2 2.4 2.5
Net new Assets 24 30 25 25 26 26 26 -293% 27% -16% 1% 1% 1% 1%
Performance -5.4% 6.7% 3.0% 2.0% 2.0% 2.0% 2.0%
Invested Assets 750 830 880 923 967 1,012 1,058 -2% 11% 6% 5% 5% 5% 5%
Margin (bps) 101 90 87 86 85 85 85
Cost Income 68% 68% 63% 61% 61% 61% 60%
Basel 3 RWAs 16.6 18.2 19.3 19.9 20.5 21.1 22.4
PBT/Avg RWAs 14.0% 13.1% 14.8% 15.3% 15.5% 15.9% 16.1%
U/L Ro B3E at 10% CT1 99% 93% 105% 108% 110% 113% 114%
Source: Liberum Capital
In Retail and corporate: we assume flat revenues and some declines in costs(due to restructuring programme) with the cost income ratio towards the low end
of the guided 50-60% range.
Figure 39: UBS Retail and Corporate Division Underlying
% Ch
CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e
Revenues 3.9 3.7 3.7 3.7 3.7 3.7 3.7 -1% -4% 0% 0% 0% 0% 0%
Staff cost -1.7 -1.4 -1.3 -1.3 -1.3 -1.3 -1.4 3% -18% -1% -1% 0% 0% 2%
Other expenses -0.5 -0.8 -0.6 -0.6 -0.6 -0.6 -0.6 -1% 64% -24% 0% 0% 0% 3%
Total expenses -2.1 -2.1 -1.9 -1.9 -1.9 -1.9 -2.0 2% -1% -9% -1% 0% 0% 2%
PIP 1.8 1.6 1.8 1.8 1.8 1.8 1.7 -5% -8% 11% 0% -1% 0% -3%
Loan losses -0.1 0.0 0.0 0.0 0.0 0.0 0.0
Underlying PBT 1.7 1.6 1.8 1.8 1.8 1.8 1.7 -6% -3% 12% 0% -1% 0% -3%
Rev 1-offs 0.3 0.0 0.0 0.0 0.0 0.0 0.0
Cost 1-offs 0.0 0.2 0.0 0.0 0.0 0.0 0.0
1-offs 0.3 0.2 0.0 0.0 0.0 0.0 0.0
Reported PBT 1.9 1.8 1.8 1.8 1.8 1.8 1.7
PAT 1.3 1.3 1.4 1.4 1.4 1.4 1.3
Underlying attributable 1.2 1.1 1.3 1.3 1.3 1.3 1.2
Invested assets 848 361 374 387 401 415 429
Cost Income 55% 57% 51% 51% 52% 52% 53%
Basel 3 RWAs 33.1 38.4 40.2 40.9 41.5 42.2 42.9
PBT/Avg RWAs 4.9% 4.5% 4.6% 4.4% 4.3% 4.2% 4.1%
U/L Ro B3E at 10% CT1 35% 32% 32% 31% 31% 30% 29%
Source: Liberum Capital
Asset Management:As in Wealth management we assume asset performanceof c2% per annum and some improvement in costs due to the restructuring
bringing the cost income ratio towards the middle of the guided 60-70% range.
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
29/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
www.liberumcapital.com 29
Figure 40: UBS Global Asset Management Division Underlying
% Ch
CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e
Revenues 1.8 1.9 1.9 2.0 2.0 2.1 2.2 -12% 4% 4% 3% 3% 3% 3%
Staff cost -1.0 -0.9 -0.9 -0.9 -0.9 -0.9 -0.9 -14% -5% -2% -1% 1% 2% 2%
Other expenses -0.4 -0.5 -0.4 -0.4 -0.4 -0.4 -0.4 -9% 16% -7% -1% 1% 2% 2%Total expenses -1.3 -1.4 -1.3 -1.3 -1.3 -1.3 -1.4 -12% 1% -4% -1% 1% 2% 2%
PIP 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%
Loan losses 0 0 0 0 0 0 0
Underlying PBT 0.5 0.5 0.6 0.7 0.7 0.8 0.8 -12% 11% 24% 11% 6% 4% 4%
Rev 1-offs 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cost 1-offs 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1-offs 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Reported PBT 0.4 0.5 0.6 0.7 0.7 0.8 0.8
PAT 0.4 0.4 0.5 0.5 0.6 0.6 0.6
U/L Attributable 0.3 0.4 0.4 0.5 0.5 0.5 0.6
Cost Income 75% 73% 68% 65% 64% 64% 63%
Basel 3 RWAs 3.6 3.5 3.6 3.7 3.8 4.0 4.1
PBT/Avg RWAs 12.8% 14.2% 17.5% 18.8% 19.4% 19.6% 19.9%
U/L Ro B3E at 10% CT1 91% 100% 124% 134% 138% 139% 141% Source: Liberum Capital
Investment Banking: We assume a sharp decline in FICC revenues cumulative 69% decline 2015e vs. 2012e as many credit and rates businesses
are exited with CHF90bn (pre 4Q12 disposals) of RWAs assets transferred to the
central legacy division to be run off. We assume equity revenues broadly flat
with some steady improvement in M&A ECM and DCM from current relatively
subdued levels.
IB cost income ratio is forecast to decline to 83%: still towards the top end ofthe guided range of 65-85%, resulting in PBT achieved of c CHF1bn and RoB3Eof c10.5% before adjusting for Dodd Frank etc.
We assume a CHF3.1bn or c69%
decline in FICC revenues 2015 vs.
2012
-
7/30/2019 Equity Research: BUY case on UBS; HOLD CS
30/47
10 January 2013 Road to Damascus: Long Paul vs. Saul
30 www.liberumcapital.com
Figure 41: UBS Investment Banking Division Underlying
% Ch
CHFbn 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e
M&A ECM DCM 1.4 1.5 1.6 1.6 1.7 1.7 1.8 -43% 9% 4% 4% 4% 4% 4%
Equities 3.7 3.1 3.1 3.2 3.2 3.2 3.2 -17% -17% 2% 2% 0% 0% 0%
FICC 4.7 4.5 3.2 2.4 1.4 1.4 1.4 -4% -5% -28% -25% -42% 0% 0%Revenues 9.8 9.0 7.9 7.2 6.3 6.3 6.4 -17% -7% -12% -9% -13% 1% 1%
Staff cost -5.6 -4.9 -4.3 -3.8 -3.2 -3.2 -3.2 -14% -12% -13% -12% -16% 1% 1%
Other expenses -3.1 -3.2 -2.8 -2.4 -2.0 -2.0 -2.1 0% 4% -13% -15% -15% 1% 1%
Total expenses -8.7 -8.1 -7.1 -6.2 -5.2 -5.2 -5.3 -9% -6% -13% -13% -16% 1% 1%
PIP 1.1 0.9 0.8 1.1 1.1 1.1 1.1 -50% -16% -9% 30% 0% 1% 1%
Loan losses 0.0 0.0 0.0 -0.1 -0.1 -0.1 -0.1
U/L PBT 1.1 0.9 0.8 1.0 1.0 1.0 1.1 -49% -15% -15% 29% 0% 1% 1%
Rev 1-offs IBD 0.00 0.0 0.00 0.00 0.00 0.00 0.00
Rev 1-offs Equities -1.9 -0.4 0.00 0.00 0.00 0.00 0.00
Rev 1-offs FICC -0.3 0.0 0.00 0.00 0.00 0.00 0.00
Rev 1-offs -2.1 -0.4 0.00 0.00 0.00 0.00 0.00
Costs 1-offs -0.2 -3.1 0.00 0.00 0.00 0.00 0.00
FVOD 1.5 0.0 0.00 0.00 0.00 0.00 0.00
1-offs -0.8 -3.5 0.00 0.00 0.00 0.00 0.00
Reported PBT 0.3 -2.5 0.8 1.0 1.0 1.0 1.1 U/L PAT 0.9 0.7 0.6 0.8 0.8 0.8 0.8
U/L Attributable 0.8 0.7 0.6 0.7 0.7 0.7 0.7
Cost Income 89% 90% 89% 85% 83% 83% 83%
Basel 3 RWAs 270.2 72.0 70.0 70.0 70.0 70.0 70.0
Clean PBT/Avg RWAs 0.4% 0.6% 1.1% 1.5% 1.5% 1.5% 1.5%
U/L Ro B3E at 10% CT1 2.8% 3.9% 8.0% 10.5% 10.4% 10.6% 10.7%
Source: Liberum Capital
Wealth Management Americas (WMA) division: We assume relatively goodrevenues and positive jaws vs. slower growing expenses in 2013e driving strong
bottom line growth. Given the groups large but time-limited Unrecognised
Potential DTAs in the the US, we would expect driving PBT growth in the WMA
division to be a strategic imperative.
Figure 42: UBS Wealth Management Americas Division Underlying
% Ch
CHFbn 2010 2011 2012e 2013e 2014e 2015e 2016e 2017e 2011 2012e 2013e 2014e 2015e 2016e 2017e
Revenues 5.6 5.2 6.1 6.4 6.7 6.9 7.2 7.4 -6% 16% 6% 4% 4% 4% 4%
Staff cost -4.2 -3.8 -4.3 -4.4 -4.5 -4.6 -4.7 -4.9 -9% 12% 2% 2% 3% 3% 4%
Other expenses -1.1 -0.9 -1.0 -1.0 -1.0 -1.0 -1.0 -1.1 -15% 4% 1% 2% 3% 3% 3%
Total expenses -5.3 -4.7 -5.2 -5.3 -5.4 -5.6 -5